Although anti-VEGF agents have become a standard treatment for AMD, DME, RVO with ME, and other retinal diseases, only limited information is available concerning the influence of the anti-VEGF agents on the fellow eye especially during the early periods. Here, VEGFA is linked to age-related macular degeneration.